Impact of preoperative overt hepatic encephalopathy on neurocognitive function after Liver transplantion

Liver Transplantation

Volumn 15, Issue 2, 2009, Pages 184-192

  Sotil, Eva U ^a   Gottstein, Jeanne ^a   Ayala, Edgar ^b   Randolph, Christopher ^c   Blei, Andres T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL FLICKER FUSION; FEMALE; GRAFT RECIPIENT; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER TRANSPLANTATION; MALE; NEUROPSYCHOLOGICAL TEST; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SHORT FORM 36;

ADOLESCENT; ADULT; AGED; COGNITION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 67649200866     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21593     Document Type: Article

References (35)

1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
2. Planas R, Balleste B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004;40:823-830.
3. Guarino M, Benito-Leon J, Decruyenaere J, Schmutzhard E, Weissenborn K, Stracciari A. EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol 2006;13:2-9.
4. Stracciari A, Guarino M. Neuropsychiatric complications of liver transplantation. Metab Brain Dis 2001;16:3-11.
5. Wolcott D, Norquist G, Busuttil R. Cognitive function and quality of life in adult liver-transplant recipients. Transplant Proc 1989;21:3563.
6. Tarter RE, Switala J, Arria A, Plail J, Vanthiel DH. Subclinical hepatic-encephalopathy - comparison before and after orthotopic liver-transplantation. Transplantation 1990;50:632-637.
7. Arria AM, Tarter RE, Starzl TE, Vanthiel DH. Improvement in cognitive-functioning of alcoholics following orthotopic liver-transplantation. Alcohol Clin Exp Res 1991;15:956-962.
8. Hockerstedt K, Kajaste S, Muuronen A, Raininko R, Seppalainen AM, Hillbom M. Encephalopathy and neuropathy in end-stage liver-disease before and after liver-transplantation. J Hepatol 1992;16:31-37.
9. Riether AM, Smith SL, Lewison BJ, Cotsonis GA, Epstein CM. Quality-of-life changes and psychiatric and neurocognitive outcome after heart and liver-transplantation. Transplantation 1992;54:444-450.
10. Ciancio A, Marchet A, Saracco G, Carucci P, Lavezzo B, Leotta D et al. Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl 2002;8:630-635.
11. Rothenhausler HB, Ehrentraut S, Kapfhammer HP, Lang C, Zachoval R, Bilzer M, et al. Psychiatric and psychosocial outcome of orthotopic liver transplantation. Psychother Psychosom 2002;71:285-297.
12. Jackson EW, Zacks S, Zinn S, Ryan J, Johnson MW, Gerber DA, et al. Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled study. Liver Transpl 2002;8:932-936.
13. Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 2003;15:84-89.
14. O'Carroll RE, Couston M, Cossar J, Masterton G, Hayes PC. Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transpl 2003;9:712-720.
15. Lewis MB, Howdle PD. Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors. Liver Transpl 2003;9:1145-1148.
16. Mattarozzi K, Stracciari A, Vignatelli L, D'Alessandro R, Morelli MC, Guarino M. Minimal hepatic encephalopathy - longitudinal effects of liver transplantation. Arch Neurol 2004;61:242-247.
17. Mechtcheriakov S, Graziadei IW, Mattedi M, Bodner T, Kugener A, Hinterhuber HH, et al. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl 2004;10:77-83.
18. Kril JJ, Butterworth RF. Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with endstage liver disease. Hepatology 1997;26:837-841.
19. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-773.
20. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
21. Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998;20:310-319.
22. Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia. I: Sensitivity, reliability, and validity. Am J Psychiatry 1999;156:1944-1950.
23. Larson EB, Kirschner K, Bode RK, Heinemann AW, Clorfene J, Goodman R. Brief cognitive assessment and prediction of functional outcome in stroke. Top Stroke Rehabil 2003;9:10-21.
24. Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clini Neurosci 2006;60:174-181.
25. Mooney S, Hasssanein TI, Hilsabeck RC, Ziegler EA, Carlson M, Maron LM, et al. Utility of the repeatable battery for the assessment of neuropsychological status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol 2007;22:175-186.
26. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35:357-366.
27. Smith JM, Misiak H. Critical flicker frequency (Cff) and psychotropic-drugs in normal human subjects. Psychopharmacology (Berl) 1976;47:175-182.
28. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). 1. Conceptual-framework and item selection. Med Care 1992;30:473-483.
29. Norris ER, Smallwood GA, Connor K, McDonell K, Martinez E, Stieber AC, et al. Prevalence of depressive symptoms in patients being evaluated for liver transplantation. Transplant Proc 2002;34:3285-3286.
30. Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
31. Weissenborn K. PHES: One label, different goods?! J Hepatol 2008; (in press) epub July 8.
32. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996;53:758-763.
33. Tome S, Wells JT, Said A, Lucey MR. Quality of life after liver transplantation. A systematic review. J Hepatol 2008;48:567-577.
34. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005;42:S45-S53.
35. Rao KVR, Panickar K, Jayakumar AR, Norenberg MD. Astrocytes protect neurons from ammonia toxicity. Neurochem Res 2005;30:1311-1318.